Vycor Medical (NovaVision) buys SightScience

Vycor Medical, the company that owns NovaVision, has bought all shares in SightScience, a company previously owned by Professor Arash Sahraie and Aberdeen University. This company produces "Neuro-Eye Therapy", which intends to increase visual sensitivity to specific stimuli in "blind" visual field. For a minimum of 5 years Professor Sahraie will be NovaVision's Chief Scientific Officer, according to this press release from NovaVision. The company hopes this move will "considerably strengthen NovaVision’s ability to penetrate the European market and increase European revenues". It notes particularly that "Sight Science has a strong position in the UK".